Growth Metrics

Catalyst Pharmaceuticals (CPRX) Profit After Tax (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.94%
Dec 31, 2025 -0.16%
Sep 30, 2025 1.30%
Jun 30, 2025 -8.16%
Mar 31, 2025 1.43%
Dec 31, 2024 27.46%
Sep 30, 2024 7.57%
Jun 30, 2024 75.27%
Mar 31, 2024 -33.20%
Dec 31, 2023 213.26%
Sep 30, 2023 -181.47%
Jun 30, 2023 27.71%
Mar 31, 2023 16.08%
Dec 31, 2022 11.97%
Sep 30, 2022 5.22%
Jun 30, 2022 63.27%
Mar 31, 2022 42.24%
Dec 31, 2021 -9.88%
Sep 30, 2021 -15.20%
Jun 30, 2021 58.96%
Mar 31, 2021 -33.00%
Dec 31, 2020 -73.61%
Sep 30, 2020 343.15%
Jun 30, 2020 -6.20%
Mar 31, 2020 31.48%
Dec 31, 2019 -41.82%
Sep 30, 2019 24.36%
Jun 30, 2019 1,800.53%
Mar 31, 2019 95.56%
Dec 31, 2018 -84.97%
Sep 30, 2018 -31.41%
Jun 30, 2018 -4.65%
Mar 31, 2018 -5.79%
Dec 31, 2017 -28.96%
Sep 30, 2017 -7.67%
Jun 30, 2017 21.89%
Mar 31, 2017 -19.31%
Dec 31, 2016 -5.29%
Sep 30, 2016 13.46%
Jun 30, 2016 15.17%
Mar 31, 2016 7.38%
Dec 31, 2015 -30.71%
Sep 30, 2015 2.40%
Jun 30, 2015 15.74%
Mar 31, 2015 -55.02%
Dec 31, 2014 30.34%
Sep 30, 2014 -56.66%
Jun 30, 2014 16.09%
Mar 31, 2014 -181.33%
Dec 31, 2013 77.09%
Sep 30, 2013 -88.07%
Jun 30, 2013 -80.22%
Mar 31, 2013 -2,177.59%
Dec 31, 2012 97.08%
Sep 30, 2012 -806.85%
Jun 30, 2012 73.46%
Mar 31, 2012 53.69%
Dec 31, 2011 -108.53%
Sep 30, 2011 19.10%
Jun 30, 2011 8.11%
Mar 31, 2011 -108.18%
Dec 31, 2010 19.38%